Tirzepatide (Tirz)
-
Detail
Tirzepatide (Tirz) Compound Overview
Tirzepatide (Tirz) is a peptide research entry commonly associated with combined GIP and GLP-1 receptor signaling literature. This page identifies the material as Tirzepatide (Tirz), with amino acid count 39; synonyms Tirzepatide; LY3298176. The Tirzepatide (Tirz) identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.
Dual-Receptor Peptide Research Context
The research record for Tirzepatide (Tirz) is organized around GIP and GLP-1 receptor research, dual-receptor ligand profiling, signal-response analysis, and analytical peptide characterization. For Tirzepatide (Tirz), those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.
Available Tirzepatide (Tirz) Specifications
The live selector currently lists 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg for Tirzepatide (Tirz), supplied as 10 Vials. Each selectable Tirzepatide (Tirz) specification retains its own SKU, displayed price, inventory record, and matched image, so the chosen option can be checked without relying on a generic dose range.
Tirzepatide (Tirz) Identity & Composition
Compound / Blend Tirzepatide (Tirz) Available Specifications 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg Pack Format 10 Vials CAS Number 2023788-19-2 Molecular Formula C225H348N48O68 Molecular Weight 4813.53 g/mol Amino Acid Count 39 Sequence 39-residue GIP-based peptide with Aib at positions 2 and 13, a C-terminal amide, and Lys20 attached to a C20 diacid through a linker. Synonyms Tirzepatide; LY3298176 Physical Form Lyophilized powder Record boundary: Molecular identifiers describe the named Tirzepatide (Tirz) form; lot-specific analytical results remain in the matched COA record.
How to Read the Tirzepatide (Tirz) COA
Use the Certificate of Analysis panel to review documentation available for Tirzepatide (Tirz). When examining a record, confirm the product name, selected specification, batch number, test date, reported purity, net content, and the tests included. The Tirzepatide (Tirz) identity table and batch documentation serve different purposes, so catalogue identifiers should be evaluated separately from lot-specific analytical results.
Research Use Notice
This material is supplied for controlled laboratory and research use only. It is not intended for human or animal consumption, diagnosis, treatment, administration, or therapeutic use. Buyers should review the selected specification and its matched documentation before ordering.
Related Products
Compare other listings in the GLP-1 Peptides collection.
Related Research Guides
-
Customer ReviewsNo comments
USD



